Register entry

Averitas Pharma, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
5
Labeller names
2
Live patents
6
Countries
0
Catalogue

Drug listings by form and route

5

5 active NDC listings: 5 human prescription drug. By marketing category: NDA 5.

Dosage formNDCs
kit3
tablet, film coated2
RouteNDCs
oral2
Labeller name on the listingNDCs
averitas pharma inc3
averitas pharma, inc.2
Exclusivity

Patents and exclusivities

6
PatentProductCoversExpiry
7786133MOVANTIKnaloxegol oxalatesubstance, productSept 2028
9226903QUTENZAcapsaicinproductDec 2028
8821920QUTENZAcapsaicinproductMar 2030
9012469MOVANTIKnaloxegol oxalatesubstance, productApr 2032
Catalogue

Marketed products

5
BrandGeneric nameForm / routeNDC
MOVANTIKnaloxegol oxalatetablet, film coated, oral82625-8801NDA
MOVANTIKnaloxegol oxalatetablet, film coated, oral82625-8802NDA
Qutenzacapsaicinkit72512-928NDA
Qutenzacapsaicinkit72512-929NDA
Qutenzacapsaicinkit72512-930NDA
Compare

Other companies listing capsaicin

Enquiry

Common questions

Is Averitas Pharma, Inc. FDA approved?
Averitas Pharma, Inc. holds no registered establishment of its own; 5 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Averitas Pharma, Inc. make?
5 products are listed under Averitas Pharma, Inc. in the openFDA NDC Directory, most often as kit; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.